SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh strong cloud infrastructure growth against concerns over high capital expenditures and a previously disclosed stock-trading plan by Chairman Larry Ellison. The conversation is largely divided between bullish investors who view the recent price drop as a buying opportunity given the company's AI-driven backlog and bears who are concerned about debt levels and potential equity dilution.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

The conversation surrounding QMCO is largely driven by concerns over a significant share overhang from pre-existing institutional investors and anticipated dilution. While some traders view the company's autonomous data management initiatives as a positive catalyst, the dominant sentiment remains skeptical, with many focusing on the disconnect between the stock's valuation and its financial performance.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Traders are intensely debating the stock's recent volatility and downward pressure following earnings, with many viewing the dip as a significant buying opportunity for a company with strong growth potential in AI connectivity. While some investors express frustration over the lack of sustained recovery and recent S&P 500 inclusion speculation that failed to materialize, a large portion of the community remains bullish, citing strong fundamentals and long-term infrastructure demand.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as traders discuss potential catalysts including upcoming medical conferences in Seoul and New York, speculation about government funding for the company's Dunkirk manufacturing facility, and the broader clinical application of its Anktiva treatment. The conversation remains heavily focused on the company's competitive position against established oncology therapies, with many in the community expressing frustration over recent price volatility and sustained short interest.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a recent disclosure that CEO Ryan Cohen purchased one million shares on the open market, an action that has fueled speculation among investors regarding potential share buybacks and future corporate strategy. While bullish traders view the insider buying as a significant signal of strength and a potential catalyst for a short squeeze, some remain skeptical, pointing to historical dilution and questioning the company's long-term business trajectory.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is experiencing high volatility as traders react to shifting developments in U.S.-Iran relations, particularly fluctuations in conflict levels and ongoing negotiations regarding shipping access in the Strait of Hormuz. Community sentiment remains polarized, with some traders betting on further supply disruptions and others anticipating a bearish reversal as global oil production ramps up.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is discussing the rapid collapse of the $LAPTOP.X meme coin, with many traders describing the sharp price decline following its launch as a classic "rug pull." While some participants express frustration over significant financial losses, others are debating the speculative nature of politically-themed meme tokens.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) shares declined significantly amid community speculation regarding a third-party clinical trial survival model and concerns over a prolonged quiet period. While traders debated the potential for a trial failure versus a delayed event rate signaling therapeutic efficacy, institutional ownership levels remain a focal point of contention among investors.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as traders closely monitor progress for its lead oncology asset, ivonescimab, particularly following updated overall survival results from the Phase III HARMONi trial and ahead of a key regulatory decision. Community conversation is driven by optimism regarding the drug's potential to compete with established treatments and positive insider buying activity, despite some uncertainty and debate over regulatory pathways.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant investor attention as traders debate whether the stock's recent decline is a manipulated shakeout by institutional players or a broader sector rotation away from healthcare. While some express frustration over the ongoing selloff, many investors remain bullish, pointing to strong earnings fundamentals, increased share buyback plans, and historical midterm year performance as reasons to hold or accumulate shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JANX just one data release can take it to 50+  , we still have institutions in this play even after the push to 70+ ( the one from begning has added more not sold ) .. think of it almost 1 billon in cash and a platform which most of the big pharma company want to use it and plus the JANX007 which they have data expected anytime soon ...

Lucas Peters

Rich Irizarry

Mike white

Shawn Swicegood

LabPsycho

Michael M

StockTwits Web

Janux Therapeutics Inc

 just one data release can take it to 50+  , we still have institutions in this play even after the push to 70+ ( the one from begning has added more not sold ) .. think of it almost 1 billon in cash and a platform which most of the big pharma company want to use it and plus the JANX007 which they have data expected anytime soon ...

IllogicalMarket

@IllogicalMarket this is cope. im still in it but theres no data to expect ”soon”. maybe end of the year

 this is cope. im still in it but theres no data to expect ”soon”. maybe end of the year

Naser A

@IllogicalMarket  - money in space or AI stocks. Look at where wall street is putting it&#39;s money and it is definitely not biotech for 2026.

  - money in space or AI stocks. Look at where wall street is putting it's money and it is definitely not biotech for 2026.